Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
A randomized, double blind phase III treatment trial (Parallel Assignment) evaluating Difelikefalin in patients undergoing Hemodialysis (End-stage renal disease (ESRD))
Primary outcome measures
Reduction of Itch Intensity due to pruritus as Assessed by the Percentage of Patients Achieving an Improvement From Baseline ≥3 Points With Respect to the Weekly Mean of the Daily 24-hour Worst Itching Intensity Numerical Rating Scale (NRS) Score at Week 12
Conclusion
The treatment with difelikefalin led to a notable decrease in itch intensity and enhanced the quality of life related to [itching](brain://y…